1. Erlotinib plus bevacizumab versus erlotinib alone in patients with EGFR-positive advanced non-squamous non-small-cell lung cancer (NEJ026): interim analysis of an open-label, randomised, multicentre, phase 3 trial. Issue 5 (May 2019) Authors: Saito, Haruhiro; Fukuhara, Tatsuro; Furuya, Naoki; Watanabe, Kana; Sugawara, Shunichi; Iwasawa, Shunichiro; Tsunezuka, Yoshio; Yamaguchi, Ou; Okada, Morihito; Yoshimori, Kozo; Nakachi, Ichiro; Gemma, Akihiko; Azuma, Koichi; Kurimoto, Futoshi; Tsubata, Yukari; Fujita, Yuka; Nagashima, Hiromi; Asai... Journal: Lancet oncology Issue: Volume 20:Issue 5(2019) Page Start: 625 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs. Issue 6 (19th April 2018) Authors: Masuda, Ken; Tokito, Takaaki; Azuma, Koichi; Yanagida, Eriko; Nakamura, Masayuki; Naito, Yoshiko; Matsuo, Norikazu; Ishii, Hidenobu; Yamada, Kazuhiko; Akiba, Jun; Hoshino, Tomoaki Journal: Thoracic cancer Issue: Volume 9:Issue 6(2018) Page Start: 754 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FP037Functional significance of angiotensin II type 1 receptor signaling in mouse distal convoluted tubule cells. (13th June 2019) Authors: Azuma, Koichi Journal: Nephrology dialysis transplantation Issue: Volume 34(2019)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FP535STUDY OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL SUBFRACTIONS IN CHRONIC HEMODIALYSIS PATIENTS. (18th May 2018) Authors: Taira, Takayasu; Azuma, Koichi; Takemura, Toru; Chiba, Tetsuo; Go, Oda; Hirano, Tsutomu Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Longitudinal monitoring of somatic genetic alterations in circulating cell‐free DNA during treatment with epidermal growth factor receptor–tyrosine kinase inhibitors. Issue 1 (10th September 2019) Authors: Iwama, Eiji; Sakai, Kazuko; Hidaka, Noriko; Inoue, Koji; Fujii, Akiko; Nakagaki, Noriaki; Ota, Keiichi; Toyozawa, Ryo; Azuma, Koichi; Nakatomi, Keita; Harada, Taishi; Hisasue, Junko; Sakata, Shinya; Shimose, Takayuki; Kishimoto, Junji; Nakanishi, Yoichi; Nishio, Kazuto; Okamoto, Isamu Journal: Cancer Issue: Volume 126:Issue 1(2020) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FP535STUDY OF HIGH-DENSITY LIPOPROTEIN CHOLESTEROL SUBFRACTIONS IN CHRONIC HEMODIALYSIS PATIENTS. (18th May 2018) Authors: Taira, Takayasu; Azuma, Koichi; Takemura, Toru; Chiba, Tetsuo; Go, Oda; Hirano, Tsutomu Journal: Nephrology dialysis transplantation Issue: Volume 33(2018)Supplement 1 Page Start: i219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Different responses to nivolumab therapy between primary and metastatic tumors in a patient with recurrent hypopharyngeal squamous cell carcinoma. (February 2020) Authors: Sato, Kiminobu; Ono, Takeharu; Sato, Fumihiko; Kawahara, Akihiko; Azuma, Koichi; Kawaguchi, Toshihiko; Akiba, Jun; Umeno, Hirohito Journal: Oral oncology Issue: Volume 101(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P3-1-64Noninvasive detection of acquired T790M mutation in NSCLC patients treated with EGFR-TKI using digital PCR of plasma. (30th October 2015) Authors: Ishii, Hidenobu; Azuma, Koichi; Sakai, Kazuko; Tokito, Takaaki; Yamada, Kazuhiko; Nishio, Kazuto; Hoshibo, Tomoaki Journal: Annals of oncology Issue: Volume 26(2015)Supplement 7 Page Start: vii138 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Tenofovir alafenamide after switching from entecavir or nucleos(t)ide combination therapy for patients with chronic hepatitis B. (30th April 2020) Authors: Ogawa, Eiichi; Nomura, Hideyuki; Nakamuta, Makoto; Furusyo, Norihiro; Koyanagi, Toshimasa; Dohmen, Kazufumi; Ooho, Aritsune; Satoh, Takeaki; Kawano, Akira; Kajiwara, Eiji; Takahashi, Kazuhiro; Azuma, Koichi; Kato, Masaki; Shimoda, Shinji; Hayashi, Jun Journal: Liver international Issue: Volume 40:Number 7(2020) Page Start: 1578 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Ledipasvir and sofosbuvir for 12 weeks for hepatitis C virus genotype 2 infection: A propensity score matched analysis. Issue 2 (19th November 2019) Authors: Ogawa, Eiichi; Nomura, Hideyuki; Nakamuta, Makoto; Kawano, Akira; Dohmen, Kazufumi; Kajiwara, Eiji; Satoh, Takeaki; Koyanagi, Toshimasa; Takahashi, Kazuhiro; Ooho, Aritsune; Azuma, Koichi; Furusyo, Norihiro; Kato, Masaki; Shimoda, Shinji; Hayashi, Jun Journal: Hepatology research Issue: Volume 50:Issue 2(2020) Page Start: 174 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗